NEWS
T2 CHALLENGE
FINALISTS
The Ascensia Diabetes Challenge was launched last
September. A global innovation competition, it was
introduced to fine digital solutions to support Type 2 diabetes
management. The many entries have been narrowed down
to six that will progress to the finalist stage of the challenge.
These six finalists will all receive a €10,000 cash prize to
support the further development of their ideas. Following the finalist event, prizes for
the winners and runners-up will be awarded from the total prize fund of €200,000,
with the opportunity to partner with Ascensia Diabetes Care going forward. The finalists
represent the innovative thinking as well as the latest technology to enter the field of
Type 2 diabetes management, as listed below. For information on the Ascensia Diabetes
Challenge, judges and judging criteria visit ascensiadiabeteschallenge.com
Foodient by Whisk (UK): An artificial intelligence powered Digital Dietician that connects
people to the world's leading grocery retailers. It is being developed to help Type 2
diabetes patients easily find food they love and which is nutritionally tailored so that they
can make sustainable behaviour changes. www.whisk.com
GlycoLeap by Holmusk (Singapore): A digital health program that is a simpler way to lose
weight and lower HbA1c. It combines expert human coaching with mobile technology
to empower people with Type 2 diabetes live a healthier life. GlycoLeap is powered by a
scalable, engaging and effective technology platform for data-driven, personalised health
coaching. www.glycoleap.com
QStream (USA): A team-based mobile game developed at Harvard Medical School that
can prompt meaningful behavior change in people with Type 2 diabetes. QStream is
proven to generate significant and sustained improvements in blood glucose control
among patients who use it. www.qstreamhealthcare.com
My Diabetes Coach by Macadamian (Canada): A 'voice first' diabetes management
platform that uses Amazon's Alexa to help those with Type 2 diabetes better manage
their care. The data captured through an integrated wearable device, a mobile phone,
and dialogue with the patient provides a personal virtual coaching experience that is
enabled through artificial intelligence. www.macadamian.com
Path Feel by Walk with Path UK): An active feedback insole that provides vibrational, or
haptic, feedback to the user during walking. This can aid people with diabetic neuropathy
in being able to feel the ground and achieve balance. Path Feel is a connected digital
solution and integrates data from the insole, which can be used to personalise and
enhance care. www.walkwithpath.com
xbird (Germany): Medical artificial intelligence software that analyzes micro-movements,
collected by smartphones and wearables worn by people with diabetes, and cross
references them with historical blood glucose data in order to predict and detect
potential hypo- and hyperglycaemic events. The solution creates actionable insights for
both doctors and patients. www.xbrid.io
READER OFFER
There is a reader discount
available on medical ID
Jewellery from Kirsty. If you
use code DESANG at the
checkout, you'll get 33%
off bracelets, brooches and
bookmarks.
MINI CGM
FOR T2
Verily and Dexcom are developing
miniaturized continuous glucose monitors
(CGM) to help people with Type 2 diabetes
better manage the condition. Verily and
Dexcom are focused on minimizing
the cost and size of CGM to enable
more people to control their diabetes
with timely, actionable information.
Verily is building miniaturized sensor
electronics on an adhesive patch to make
continuous monitoring less disruptive.
Smaller and more comfortable CGMs
may replace finger sticks in people with
Type 2 diabetes, and have the potential
to increase behavioural compliance and
adherence to treatment regimes.
Jewellery from Kirsty